Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clyde W Yancy

Showing results (341-350 of 383) with videos related to

Pageof 39
Sort By:
ESC Heart Failure|July 16, 2022
The development and initial validation of the PROMIS®+HF-27 and PROMIS+HF-10 profilesFaraz S Ahmad, Kathryn L Jackson, Susan E Yount, et al.
Journal of General Internal Medicine|May 5, 2025
Barriers and Facilitators to Heart Failure Guideline-Directed Medical Therapy in an Integrated Health System and Federally Qualified Health Centers: A Thematic Qualitative AnalysisSarah E Philbin, Lacey P Gleason, Stephen D Persell, et al.
Journal of the American College of Cardiology|April 29, 2026
Aligning Coronary Stent Trial Enrollment With the U.S. Intended-Use Population: Implications of Site SelectionWayne B Batchelor, Robert Califf, Roxana Mehran, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Barriers and Facilitators to Heart Failure Guideline-Directed Medical Therapy in an Integrated Health System and Federally-Qualified Health Centers: A Thematic Qualitative AnalysisSarah E Philbin, Lacey P Gleason, Stephen D Persell, et al.
American Heart Journal|August 13, 2011
Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practiceZubin J Eapen, Eric D Peterson, Gregg C Fonarow, et al.
Journal of Cardiac Failure|November 17, 2021
Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart FailureMuthiah Vaduganathan, Stephen J Greene, Shuaiqi Zhang, et al.
Circulation. Heart Failure|October 9, 2024
Home-Time, Mortality, and Readmissions Among Patients Hospitalized With Heart Failure: A Baseline Prior to IMPLEMENT-HFAmber B Tang, Nicole Solomon, Karen Chiswell, et al.
Journal of the American Heart Association|August 5, 2021
Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection FractionStephen J Greene, Sujung Choi, Steven J Lippmann, et al.
JAMA Cardiology|November 13, 2020
Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) RegistryMuthiah Vaduganathan, Stephen J Greene, Shuaiqi Zhang, et al.
Journal of the American College of Cardiology|May 14, 2021
Kidney Function and Outcomes in Patients Hospitalized With Heart FailureRavi B Patel, Gregg C Fonarow, Stephen J Greene, et al.
Pageof 39

Showing results (341-350 of 383) with videos related to

Sort By:
Pageof 39
ESC Heart Failure|July 16, 2022
The development and initial validation of the PROMIS®+HF-27 and PROMIS+HF-10 profilesFaraz S Ahmad, Kathryn L Jackson, Susan E Yount, et al.
Journal of General Internal Medicine|May 5, 2025
Barriers and Facilitators to Heart Failure Guideline-Directed Medical Therapy in an Integrated Health System and Federally Qualified Health Centers: A Thematic Qualitative AnalysisSarah E Philbin, Lacey P Gleason, Stephen D Persell, et al.
Journal of the American College of Cardiology|April 29, 2026
Aligning Coronary Stent Trial Enrollment With the U.S. Intended-Use Population: Implications of Site SelectionWayne B Batchelor, Robert Califf, Roxana Mehran, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Barriers and Facilitators to Heart Failure Guideline-Directed Medical Therapy in an Integrated Health System and Federally-Qualified Health Centers: A Thematic Qualitative AnalysisSarah E Philbin, Lacey P Gleason, Stephen D Persell, et al.
American Heart Journal|August 13, 2011
Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practiceZubin J Eapen, Eric D Peterson, Gregg C Fonarow, et al.
Journal of Cardiac Failure|November 17, 2021
Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart FailureMuthiah Vaduganathan, Stephen J Greene, Shuaiqi Zhang, et al.
Circulation. Heart Failure|October 9, 2024
Home-Time, Mortality, and Readmissions Among Patients Hospitalized With Heart Failure: A Baseline Prior to IMPLEMENT-HFAmber B Tang, Nicole Solomon, Karen Chiswell, et al.
Journal of the American Heart Association|August 5, 2021
Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection FractionStephen J Greene, Sujung Choi, Steven J Lippmann, et al.
JAMA Cardiology|November 13, 2020
Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) RegistryMuthiah Vaduganathan, Stephen J Greene, Shuaiqi Zhang, et al.
Journal of the American College of Cardiology|May 14, 2021
Kidney Function and Outcomes in Patients Hospitalized With Heart FailureRavi B Patel, Gregg C Fonarow, Stephen J Greene, et al.
Pageof 39